Efpeglenatide and Clinical Outcomes with and without Concomitant Sodium-Glucose Co-Transporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial - Lam, CSP; Ramasundarahettige, C; Branch, KRH (Circulation, 2021)
et al.